|
|
Vaccine Detail
|
VXS-1223 |
| Vaccine Information |
- Vaccine Name: VXS-1223
- Target Pathogen: SARS-CoV-2
- Target Disease: COVID-19
- Manufacturer: Vaxxas Pty Ltd
- Vaccine Ontology ID: VO_0005404
- Type: Subunit vaccine
- Status: Clinical trial
- Host Species for Licensed Use: Human
- Immunization Route: Intradermal injection (i.d.)
|
| Host Response |
|
|
| References |
|
|
|
